Quest Diagnostics Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Quest Diagnostics Inc. (DGX) on March 9, 2026. The filing reports a corporate governance event involving the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a director appointment and does not contain financial performance data.
Material Changes
The material change reported is the election of a new director to the Board of Directors.
- New Director: Timothy Wentworth, former CEO of Walgreens Boots Alliance.
- Committee Assignments: Compensation and Leadership Development Committee; Quality and Compliance Committee.
- Independence: Determined to be an independent director per NYSE standards.
- Compensation: Received a prorated one-time grant of restricted share units valued at approximately $43,000.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document serves solely to disclose the director election and associated compensation.
Investor Verification Checklist
- Verify the effective date of Timothy Wentworth's board membership.
- Review the full press release (Exhibit 99.1) for additional context on the appointment.
- Confirm the specific terms of the restricted share unit grant in the company's director compensation policy.
- Check subsequent filings for any impact on board committee composition or voting dynamics.